Home / Import refusals / AEK-9375889-2/30003/1

FDA Import Refusal AEK-9375889-2/30003/1 — Intas Pharmaceuticals Ltd

Intas Pharmaceuticals Ltd — FEI 3013501434

The FDA refused shipment AEK-9375889-2/30003/1 from Intas Pharmaceuticals Ltd (India) on February 10, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 10, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
Charges
75

Other import refusals

  • 1FX-3824380-4/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1919971-7/50003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9186485-8/190003/1 (Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9094971-3/30003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9094971-3/10003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources